|  | DFS (Univariate analysis) | DFS (Multivariate analysis) | ||
---|---|---|---|---|---|
 |  | HR (95% CI)* | P** | HR (95% CI)* | P** |
Age | > = 60 vs <60 | 3.34 (1.44-7.71) | 0.01 |  |  |
Sex | Male vs Female | 1.06 (0.40-2.81) | 0.91 | Â | Â |
Site | Tonsil, BOT vs Other | Â | Â | Â | Â |
T stage | 3,4 vs 1,2 | 1.00 (0.46-2.17) | 0.99 | Â | Â |
N stage | N + vs N0 | 0.51 (0.22-1.18) | 0.11 |  |  |
Smoking | >10 py vs < 10 py or unknown | 1.54 (0.64-3.72) | 0.34 |  |  |
Alcohol | >21 drinks vs <21 drinks and Unknown | 0.94 (0.33-2.75) | 0.92 | Â | Â |
p16 | Positive vs Negative | 0.41 (0.19-0.90) | 0.025 | Â | Â |
All High-Risk HPV | Positive vs Negative | 0.25 (0.11-0.58) | 0.001 | 0.24 (0.10-0.56) | 0.001 |
HPV 16 only | Positive vs Negative | 0.27 (0.11-0.65) | 0.003 | Â | Â |
 |  | OS (Univariate Analysis) | OS (Multivariate Analysis) | ||
 |  | HR (95% CI)* | P** | HR (95% CI)* | P** |
Age | > = 60 vs <60 | 3.05 (1.06-8.80) | 0.04 |  |  |
Sex | Male vs Female | 0.70 (0.23-2.17) | 0.53 | Â | Â |
Site | Tonsil, BOT vs Other | 1.38 (0.39-4.90) | 0.61 | Â | Â |
T stage | 3,4 vs 1,2 | 1.76 (0.61-5.07) | 0.30 | Â | Â |
N stage | N + vs N0 | 0.37 (0.13-1.01) | 0.05 |  |  |
Smoking | >10 py vs < 10 py or unknown | 2.34 (0.67-8.25) | 0.19 |  |  |
Alcohol | >21 drinks vs <21 drinks and Unknown | 1.16 (0.33-4.09) | 0.81 | Â | Â |
p16 | Positive vs Negative | 0.24 (0.09-0.67) | 0.006 | Â | Â |
All High-Risk HPV | Positive vs Negative | 0.20 (0.06-0.62) | 0.005 | 0.19 (0.06-0.60) | 0.004 |
HPV 16 only | Positive vs Negative | 0.17 (0.05-0.59) | 0.006 | Â | Â |